Galectin Therapeutics (GALT) Long-Term Investments (2014)
Galectin Therapeutics' (GALT) quarterly Long-Term Investments came in at $400000.0 in Q3 2014, up 534.92% quarter-over-quarter from $63000.0 in Q2 2014.
Galectin Therapeutics (GALT) Long-Term Investments (2014) Analysis & Trends
Galectin Therapeutics' Long-Term Investments history runs 1 years deep, the most recent figure standing at $400000.0 for Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 400,000.00 |
| Jun 30, 2014 | 63,000.00 |
| Mar 31, 2014 | 130,000.00 |